Welcome!

News Feed Item

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022

LONDON, March 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022


EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022

Summary

Overweight and obesity are characterized by abnormal or excessive fat accumulation in the body, which can increase the likelihood of developing type 2 diabetes and cardiovascular diseases. Obesity is an escalating public health problem with an increasing worldwide prevalence and has become a well-known threat to public health. As obesity is a complex condition associated with a wide range of lifestyle, genetic, social, cultural, and environmental factors, its prevalence may vary across countries, depending on the variations in these contributing factors.

GlobalData's epidemiological analysis forecasts that prevalent cases of overweight in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, Brazil, and Canada) will increase from 250.05 million in 2012 to 271.86 million cases in 2022 at an annual growth rate (AGR) of 0.86%. Approximately 57% of the 250.05 million prevalent cases of overweight adults in the 9MM in 2012 were in men. GlobalData epidemiologists forecast that there were 167.39 million prevalent cases of obesity in the 9MM in 2012, which will increase to 213.34 million cases in 2022, increasing at an AGR of 2.75%. Approximately 52% of the 167.39 million prevalent cases of obese adults in the 9MM in 2012 were in women.

According to GlobalData's forecast, the prevalent cases of both overweight and obesity will increase dramatically over the next decade, with the number of obese adults increasing by an alarming 27.50%. Overweight and obesity have reached pandemic proportions; however, GlobalData epidemiologists believe that with the alarming increase in the prevalence of both overweight and obesity, the morbidity and mortality associated with the disease will continue to increase dramatically as well.

Scope

- The Overweight and Obesity EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of overweight and obesity in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, Brazil, and Canada). It includes a 10-year epidemiology forecast of the prevalent cases of overweight, obesity, obesity class I, obesity class II, and obesity class III segmented by sex and age. In addition, the report includes a 10-year forecast of the prevalent cases of obesity-associated comorbidities, including diagnosed diabetes, diagnosed hypertension, and dyslipidemia, among adults with overweight/obesity in some of these markets.
- The overweight and obesity epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 9MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global overweight and obesity market.
- Quantify patient populations in the global overweight and obesity market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for overweight and obesity therapeutics in each of the markets covered.
- Identify the number of obesity class I, obesity class II, and obesity class III prevalent cases.
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 11
3 Epidemiology 12

3.1 Disease Overview 12
3.2 Risk Factors and Comorbidities 13
3.2.1 Family history is a strong predictor of obesity 13
3.2.2 Physical inactivity is an independent predictor of obesity 14
3.2.3 Excessive caloric intake doubles the risk for obesity 15
3.2.4 Hypertension is as high as 42% in obese adults 16
3.2.5 Dyslipidemia and type 2 diabetes are common comorbidities in obese patients 17
3.3 Global Trends 19
3.3.1 US 20
3.3.2 5EU 22
3.3.3 Japan 28
3.3.4 Brazil 29
3.3.5 Canada 31
3.4 Forecast Methodology 32
3.4.1 Sources Used 39
3.4.2 Forecast Assumptions and Methods: Prevalent Cases of Overweight, Obesity, Obesity by Class, and Comorbidities 46
3.4.3 Sources Not Used 63
3.5 Epidemiology Forecast of Overweight (2012–2022) 63
3.5.1 Prevalent Cases of Overweight 63
3.5.2 Age-Specific Prevalent Cases of Overweight 65
3.5.3 Sex-Specific Prevalent Cases of Overweight 67
3.5.4 Age-Standardized Prevalence of Overweight 70
3.6 Epidemiology Forecast of Obesity (2012–2022) 71
3.6.1 Prevalent Cases of Obesity 71
3.6.2 Age-Specific Prevalent Cases of Obesity 73

3.6.3 Sex-Specific Prevalent Cases of Obesity 75
3.6.4 Age-Standardized Prevalence of Obesity 76
3.7 Epidemiology Forecast of Obesity Class I (2012–2022) 77
3.7.1 Prevalent Cases of Obesity Class I 77
3.7.2 Age-Specific Prevalent Cases of Obesity Class I 79
3.7.3 Sex-Specific Prevalent Cases of Obesity Class I 81
3.7.4 Age-Standardized Prevalence of Obesity Class I 83
3.8 Epidemiology Forecast of Obesity Class II (2012–2022) 85
3.8.1 Prevalent Cases of Obesity Class II 85
3.8.2 Age-Specific Prevalent Cases of Obesity Class II 87
3.8.3 Sex-Specific Prevalent Cases of Obesity Class II 89
3.8.4 Age-Standardized Prevalence of Obesity Class II 91
3.9 Epidemiology Forecast of Obesity Class III (2012–2022) 93
3.9.1 Prevalent Cases of Obesity Class III 93
3.9.2 Age-Specific Prevalent Cases of Obesity Class III 95
3.9.3 Sex-Specific Prevalent Cases of Obesity Class III 97
3.9.4 Age-Standardized Prevalence of Obesity Class III 99
3.10 Epidemiology Forecast of Comorbidities among Adults with Overweight/Obesity (2012 and 2022) 101
3.10.1 Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity 101
3.10.2 Prevalent Cases of Diagnosed Hypertension in Adults with Overweight/Obesity 104
3.10.3 Prevalent Cases of Dyslipidemia among Adults with Overweight/Obesity 106
3.11 Discussion 109
3.11.1 Conclusions on Epidemiological Trends 109
3.11.2 Limitations of the Analysis 110

3.11.3 Strengths of the Analysis 111
4 Appendix 112
4.1 Bibliography 112
4.2 About the Authors 118
4.2.1 Epidemiologists 118
4.2.2 Reviewers 118
4.2.3 Global Director of Epidemiology and Health Policy 119
4.2.4 Global Head of Healthcare 120
4.3 About GlobalData 121
4.4 About EpiCast 121
4.5 Disclaimer 121

1.1 List of Tables

Table 1: The WHO Classification System of Adult Overweight and Obesity According to BMI 12
Table 2: Risk Factors and Comorbidities of Obesity 13
Table 3: 9MM, Age-Adjusted and Crude Prevalence (%) of Obesity, by Sex, Ages ?20 Years, 2008 20
Table 4: JASSO and WHO Classifications of Obesity 28
Table 5: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Overweight 33
Table 6: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Obesity 34
Table 7: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Obesity Class I, Class II, and Class III 36
Table 8: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Comorbidities in Overweight/Obese 38
Table 9: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 64
Table 10: 9MM, Prevalent Cases of Overweight, By Age, Both Sexes, N (Millions), Row (%), 2012 66
Table 11: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 68

Table 12: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 72
Table 13: 9MM, Prevalent Cases of Obesity, By Age, Both Sexes, N (Millions), Row (%), 2012 74
Table 14: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, by Sex, N (Millions), Row (%), 2012 75
Table 15: 9MM, Prevalent Cases of Obesity Class I, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 78
Table 16: 9MM, Prevalent Cases of Obesity Class I, by Age, Both Sexes, N (Millions), Row (%), 2012 80
Table 17: 9MM, Prevalent Cases of Obesity Class I, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 82
Table 18: 9MM, Prevalent Cases of Obesity Class II, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 86

Table 19: 9MM, Prevalent Cases of Obesity Class II, By Age, Both Sexes, N (Millions), Row (%), 2012 88
Table 20: 9MM, Prevalent Cases of Obesity Class II, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 90
Table 21: 9MM, Prevalent Cases of Obesity Class III, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 94
Table 22: 9MM, Prevalent Cases of Obesity Class III, By Age, Both Sexes, N (Millions), Row (%), 2012 96
Table 23: 9MM, Prevalent Cases of Obesity Class III, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 98
Table 24: 5MM*, Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 102
Table 25: 6MM*, Prevalent Cases of Diagnosed Hypertension among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 105
Table 26: 4MM, Prevalent Cases of Dyslipidemia* among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 107

1.2 List of Figures

Figure 1: US, Overweight and Obesity Age-Adjusted Prevalence (%), Ages 20–74 Years, Men, 1960–2010 21
Figure 2: US, Overweight and Obesity Age-Adjusted Prevalence (%), Ages 20–74 Years, Women, 1960–2010 21
Figure 3: France, Overweight and Obesity Prevalence (%), Ages ?15 Years, Men, 1997–2006 23
Figure 4: France, Overweight and Obesity Prevalence (%), Ages ?15 Years, Women, 1997–2006 23
Figure 5: Italy, Overweight and Obesity Prevalence (%), Ages ?18, Men, 1983–2010 25
Figure 6: Italy, Overweight and Obesity Prevalence (%), Ages ?18, Men, 1983–2010 25
Figure 7: UK, Overweight and Obesity Prevalence (%), Ages ?16 Years, Men, 1993–2011 27
Figure 8: UK, Overweight and Obesity Prevalence (%), Ages ?16 Years, Women, 1993–2011 27
Figure 9: Japan, Obesity Prevalence (%), Ages ?20 Years, By Sex, 1976–2006 29
Figure 10: Brazil, Overweight and Obesity Prevalence (%), Ages ?20 Years, Men, 1975–2003 30
Figure 11: Brazil, Overweight and Obesity Prevalence (%), Ages ?20 Years, Women, 1975–2003 30
Figure 12: Canada, Obesity Prevalence (%), Ages ?18 Years, Both Sexes, 1978–2008 32
Figure 13: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 65
Figure 14: 9MM, Prevalent Cases of Overweight, by Age, Both Sexes, N (Millions), 2012 67
Figure 15: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, by Sex, N (Millions), 2012 69
Figure 16: 9MM, Overweight Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 71
Figure 17: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 73

Figure 18: 9MM, Prevalent Cases of Obesity, By Age, Both Sexes, N (Millions), 2012 74
Figure 19: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, by Sex, N (Millions), 2012 76
Figure 20: 9MM, Obesity Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 77
Figure 21: 9MM*, Prevalent Cases of Obesity Class I, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 79
Figure 22: 9MM*, Prevalent Cases of Obesity Class I, By Age, Both Sexes, N (Millions), 2012 81
Figure 23: 9MM*, Prevalent Cases of Obesity Class I, Ages ?18 Years, by Sex, N (Millions), 2012 83
Figure 24: 9MM*, Obesity Class I Age-Standardized Prevalence (%), Ages ?18 Years, by Sex, 2012 84
Figure 25: 9MM*, Prevalent Cases of Obesity Class II, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 87
Figure 26: 9MM*, Prevalent Cases of Obesity Class II, By Age, Both Sexes, N (Millions), 2012 89
Figure 27: 9MM*, Prevalent Cases of Obesity Class II, Ages ?18 Years, by Sex, N (Millions), 2012 91
Figure 28: 9MM*, Age-Standardized Prevalence (%) of Obesity Class II, Ages ?18 Years, By Sex, 2012 92
Figure 29: 9MM*, Prevalent Cases of Obesity Class III, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 95
Figure 30: 9MM*, Prevalent Cases of Obesity Class III, By Age, Both Sexes, N (Millions), 2012 97
Figure 31: 9MM*, Prevalent Cases of Obesity Class III, Ages ?18 Years, By Sex, N (Millions), 2012 99
Figure 32: 9MM*, Obesity Class III Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 100
Figure 33: 5MM*, Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 103
Figure 34: 6MM*, Prevalent Cases of Diagnosed Hypertension among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 106
Figure 35: 4MM*, Prevalent Cases of Dyslipidemia** among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 108

Read the full report:
EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022
http://www.reportbuyer.com/pharma_healthcare/diseases/epicast_report_overweight_obesity_epidemiology_forecast_2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com  
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Amazon started as an online bookseller 20 years ago. Since then, it has evolved into a technology juggernaut that has disrupted multiple markets and industries and touches many aspects of our lives. It is a relentless technology and business model innovator driving disruption throughout numerous ecosystems. Amazon’s AWS revenues alone are approaching $16B a year making it one of the largest IT companies in the world. With dominant offerings in Cloud, IoT, eCommerce, Big Data, AI, Digital Assista...
Existing Big Data solutions are mainly focused on the discovery and analysis of data. The solutions are scalable and highly available but tedious when swapping in and swapping out occurs in disarray and thrashing takes place. The resolution for thrashing through machine learning algorithms and support nomenclature is through simple techniques. Organizations that have been collecting large customer data are increasingly seeing the need to use the data for swapping in and out and thrashing occurs ...
While some vendors scramble to create and sell you a fancy solution for monitoring your spanking new Amazon Lambdas, hear how you can do it on the cheap using just built-in Java APIs yourself. By exploiting a little-known fact that Lambdas aren’t exactly single threaded, you can effectively identify hot spots in your serverless code. In his session at 20th Cloud Expo, David Martin, Principal Product Owner at CA Technologies, will give a live demonstration and code walkthrough, showing how to ov...
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists will examine how DevOps helps to meet th...
SYS-CON Events announced today that A&I Solutions has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 1999, A&I Solutions is a leading information technology (IT) software and services provider focusing on best-in-class enterprise solutions. By partnering with industry leaders in technology, A&I assures customers high performance levels across all IT environments including: mai...
SYS-CON Events announced today that Cloudistics, an on-premises cloud computing company, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Cloudistics delivers a complete public cloud experience with composable on-premises infrastructures to medium and large enterprises. Its software-defined technology natively converges network, storage, compute, virtualization, and management into a ...
SYS-CON Events announced today that Outscale, a global pure play Infrastructure as a Service provider and strategic partner of Dassault Systèmes, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2010, Outscale simplifies infrastructure complexities and boosts the business agility of its customers. Outscale delivers a secure, reliable and industrial strength solution for its customers, which in...
In order to meet the rapidly changing demands of today’s customers, companies are continually forced to redefine their business strategies in order to meet these needs, stay relevant and continue to see profitable growth. IoT deployment and development is integral in this transformation, and today businesses are increasingly seeing the value of investing their resources into IoT deployments. These technologies are able increase ROI through projects such as connecting supply chains or enabling sm...
Every successful software product evolves from an idea to an enterprise system. Notably, the same way is passed by the product owner's company. In his session at 20th Cloud Expo, Oleg Lola, CEO of MobiDev, will provide a generalized overview of the evolution of a software product, the product owner, the needs that arise at various stages of this process, and the value brought by a software development partner to the product owner as a response to these needs.
SYS-CON Events announced today that EARP will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. "We are a software house, so we perfectly understand challenges that other software houses face in their projects. We can augment a team, that will work with the same standards and processes as our partners' internal teams. Our teams will deliver the same quality within the required time and budget just as our partn...
SYS-CON Events announced today that Interoute, owner-operator of one of Europe's largest networks and a global cloud services platform, has been named “Bronze Sponsor” of SYS-CON's 20th Cloud Expo, which will take place on June 6-8, 2017 at the Javits Center in New York, New York. Interoute is the owner-operator of one of Europe's largest networks and a global cloud services platform which encompasses 12 data centers, 14 virtual data centers and 31 colocation centers, with connections to 195 add...
SYS-CON Events announced today that Tappest will exhibit MooseFS at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. MooseFS is a breakthrough concept in the storage industry. It allows you to secure stored data with either duplication or erasure coding using any server. The newest – 4.0 version of the software enables users to maintain the redundancy level with even 50% less hard drive space required. The software func...
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @ThingsExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software in the hope of capturing value in IoT. Although IoT is relatively new in the market, it has already gone through many promotional terms such as IoE, IoX, SDX, Edge/Fog, Mist Compute, etc. Ultimately, irrespective of the name, it is about deriving value from independent software assets participating in an ecosystem as one comprehensive solution.
SYS-CON Events announced today that Systena America will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Systena Group has been in business for various software development and verification in Japan, US, ASEAN, and China by utilizing the knowledge we gained from all types of device development for various industries including smartphones (Android/iOS), wireless communication, security technology and IoT serv...